Delivery Order SPE2DB20D3101-SPE2DB25FRRY0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a ceiling value of $9,953.41. This delivery order is a firm fixed price contract with no set-aside designation, reflecting competitive award status. The contract is scheduled for ultimate completion by August 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,086.20 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $14,672.56 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). The contract is structured as a firm fixed price delivery order with a completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitively awarded contract. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30, with a ceiling value of $5,627.91. This is a firm fixed-price delivery order contract with an ultimate completion date of July 21, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,675.75 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a firm fixed price and an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract was issued on July 25, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,151.04 for Telmisartan-HCTZ 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of August 1, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract covers the supply of this antihypertensive pharmaceutical product to support federal...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 25, 2025, procures Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30 count) for the Defense Logistics Agency (DLA) at a firm fixed price of $1,243.56. The contract is not set-aside and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. Performance will be completed by July 28, 2025, with delivery to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRY0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count) with a ceiling value of $5,768.16. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order draws from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of pharmaceutical products and medical supplies to defense and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through multiple competitively awarded contracts with the Defense Logistics Agency, ranging from small-value transactions to substantial orders exceeding $45,000. The Telmisartan-HCTZ delivery represents routine pharmaceutical resupply supporting the Defense Health Agency and other government healthcare systems through AmerisourceBergen's flexible contract vehicle with DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/5/25 |